Adenosine is a purine nucleoside used for conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PVST). Adenosine Injection is a rapid intravenous injection used as cardiovascular drugs and antiarrhythmic agents.
This report contains market size and forecasts of Adenosine Injection in global, including the following market information:
Global Adenosine Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Adenosine Injection Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Adenosine Injection companies in 2021 (%)
The global Adenosine Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
6 mg/2 ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adenosine Injection include Astellas Pharma, Pfizer, Novartis, Sanofi, Teva Pharmaceuticals, Healthy Life Pharma and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adenosine Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adenosine Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Adenosine Injection Market Segment Percentages, by Type, 2021 (%)
6 mg/2 ml
3 mg/ml
Global Adenosine Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Adenosine Injection Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Adenosine Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Adenosine Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adenosine Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Adenosine Injection revenues share in global market, 2021 (%)
Key companies Adenosine Injection sales in global market, 2017-2022 (Estimated), (K L)
Key companies Adenosine Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Pfizer
Novartis
Sanofi
Teva Pharmaceuticals
Healthy Life Pharma
Sun Pharmaceutical